Skip to main content
. 2012 Jul 23;7(7):e41439. doi: 10.1371/journal.pone.0041439

Table 2. Echocardiographic functional data.

Group Cn = 17 Group T(-)n = 17 P
LVSD (mm) 2.91±0.57 3.42±0.53* 0.011
LVSD/BW (mm/kg) 12.1 (9.62–13.00) 12.3 (11.10–14.20)* 0.046
HR (bpm) 340.15±30.13 304.22±25.91* <0.001
CO (mL/min) 73.48±9.07 64.72±7.81* 0.005
% FS 58.012±6.98 51.70±4.82* 0.004
EF 0.92±0.03 0.88±0.03* 0.004
E wave (cm/s) 84.70±12.73 83.62±9.34 0.781
A wave (cm/s) 64.0 (52.07–75.15) 52.0 (45.75–56.00)* 0.008
E/A 1.31±0.22 1.62±0.26* 0.001
IRT (ms) 16.50 (15.0–19.00) 17.0 (15.5–18.25) 0.876
IRTc (ms) 42.5±8.8 38.0±5.5 0.084

Group C: control animals, Group T (-): taurine-deficient animals; LVSD: left ventricular systolic diameter; BW: body weight; HR: heart rate; CO: cardiac output; % FS: fractional shortening; EF: ejection fraction; E/A: relationship between the E and A waves; IRT: isovolumetric relaxation time; IRTc: isovolumetric relaxation time normalized by the HR. Data are expressed as means ± standard deviations or medians (quartile 1 - quartile 3). Bold values indicate statistical significance (P≤0.05).